Citalopram hydrobromide and Secretion discharge - a phase IV clinical study of FDA data

Summary:

Secretion discharge is reported as a side effect among people who take Citalopram hydrobromide (citalopram hydrobromide), especially for people who are male, 40-49 old, also take Sporanox, and have Asthma.

The phase IV clinical study analyzes which people have Secretion discharge when taking Citalopram hydrobromide. It is created by eHealthMe based on reports of 32,819 people who have side effects when taking Citalopram hydrobromide from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,878 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Secretion discharge?

Secretion discharge is found to be associated with 832 drugs and 784 conditions by eHealthMe. Check the latest studies of Secretion discharge.

On Jul, 08, 2026

32,819 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 42 people (0.13%) have Secretion discharge.

Could Citalopram hydrobromide cause Secretion discharge?

Among these 42 people:

What is the gender of people who have Secretion discharge when taking Citalopram hydrobromide? *

female: 24.39 %
male: 75.61 %

What is the age of people who have Secretion discharge when taking Citalopram hydrobromide? *

What are other drugs people take besides Citalopram hydrobromide? *

What are other side effects people have besides Secretion discharge? *

Cough: 32 people, 76.19%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 30 people, 71.43%
Upper Respiratory Tract Infection: 29 people, 69.05%
Sinus Congestion (blockage of sinus): 29 people, 69.05%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 29 people, 69.05%
Rashes (redness): 29 people, 69.05%
Chest Pain: 29 people, 69.05%
Weight Increased: 29 people, 69.05%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 28 people, 66.67%
Tendon Disorder (disease of tendon): 28 people, 66.67%

What are the existing conditions these people have? *

Asthma: 31 people, 73.81%
Peripheral Swelling: 4 people, 9.52%
Conjunctivitis (pink eye): 4 people, 9.52%
Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 3 people, 7.14%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 7.14%
Bipolar Disorder (mood disorder): 2 people, 4.76%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 4.76%
Parkinson's Disease: 1 person, 2.38%
Hepatitis C: 1 person, 2.38%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and have Secretion discharge?

- Check whether Secretion discharge is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Citalopram hydrobromide:

Citalopram hydrobromide (36,878 reports)

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Secretion discharge:

Secretion discharge (832 drugs)

Browse all the conditions that are associated with Secretion discharge:

Secretion discharge (784 conditions)

Related publications that referenced our studies

Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Citalopram hydrobromide) and Citalopram hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.